Evidence map›Paper›PMID 40158189›Full record

ReviewJournal of nanobiotechnology2025

Addressing the challenges of infectious bone defects: a review of recent advances in bifunctional biomaterials.

Huaiyuan Zhang, Wenyu Qiao, Yu Liu, Xizhou Yao, Yonghua Zhai, Longhai Du

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Enhancing Bone Healing with a Priming Stimulus.Life (Basel, Switzerland) · 2026
    Article
  4. Coordination-Driven CuAdvanced healthcare materials · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Bone and Infections: An Osteoimmunological Interplay.International journal of molecular sciences · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huaiyuan Zhang *Department of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Wenyu Qiao *Department of General Surgery, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Yu Liu *Research Center for Clinical Medicine, Jinshan Hospital Affiliated to Fudan University, Shanghai, 201508, China.
Xizhou YaoDepartment of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Yonghua ZhaiDepartment of Cardiovascular Medicine, Department of Hypertension, Ruijin Hospital and State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China. zhaiyonghua1201@126.com.
Longhai DuDepartment of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, 201508, China. longhaidu123@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious bone defects present a substantial clinical challenge due to the complex interplay between infection control and bone regeneration. These defects often result from trauma, autoimmune diseases, infections, or tumors, requiring a nuanced approach that simultaneously addresses infection and promotes tissue repair. Recent advances in tissue engineering and materials science, particularly in nanomaterials and nano-drug formulations, have led to the development of bifunctional biomaterials with combined osteogenic and antibacterial properties. These materials offer an alternative to traditional bone grafts, minimizing complications such as multiple surgeries, high antibiotic dosages, and lengthy recovery periods. This review examines the repair mechanisms in the infectious microenvironment and highlights various bifunctional biomaterials that foster both anti-infective and osteogenic processes. Emerging design strategies are also discussed to provide a forward-looking perspective on treating infectious bone defects with clinically significant outcomes.

Indexed as

Biocompatible MaterialsBone Diseases, InfectiousAnimalsAnti-Bacterial AgentsBone RegenerationHumansNanostructuresOsteogenesisTissue EngineeringAnti-Bacterial AgentsBiocompatible MaterialsAntibacterial propertiesBifunctional materialsBone tissue engineeringInfectious bone defectsOsteogenesis

Identifiers

PMID40158189
PMCPMC11954225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.